Nova
NVMI
377.77
-16.71
-4.24%
Nova
US · NVMI
#1302 by market cap
Listed 1970
377.77
-16.71
-4.24%
Live - 5344 symbols - heartbeat 100s ago
· 2026-10-08 06:32
Pre-market
362.11
-4.15%
After-hours
377.77
0.00%
Overnight
370.99
-1.79%
- Market cap
- 12.02B
- P/E (TTM)i
- 47.04
- P/Bi
- 8.20
- EPSi
- 7.96
- Div yieldi
- 0.00%
- 52W posi
- 32%
Reader sentiment
Are you bullish or bearish on NVMI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.87, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +30.96% YoY
Margins
- Gross margin
- 57.37%
- Operating margin
- 28.78%
- Net margin
- 29.44%
Key ratios & quality
- Enterprise valuei
- 11.71B
- PEG ratioi
- 2.07
- Altman Z-Scorei
- 8.87
PEG uses trailing P/E against the 3-year net income growth rate (22.73%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 251.13M | 224.91M | 269.40M | 416.11M | 570.73M | 517.92M | 672.40M | 880.58M |
| Gross profit | 145.23M | 121.82M | 151.17M | 235.44M | 316.97M | 293.18M | 387.09M | 505.20M |
| Selling & admin expenses | 36.73M | 38.28M | 42.58M | 57.20M | 76.58M | 72.87M | 89.29M | 108.34M |
| Research & development | 45.45M | 44.51M | 53.02M | 65.86M | 90.46M | 88.04M | 110.26M | 143.39M |
| Operating profit | 60.44M | 36.41M | 55.57M | 112.39M | 149.93M | 132.26M | 187.54M | 253.47M |
| Pretax profit | 63.43M | 39.49M | 56.50M | 109.25M | 158.41M | 154.70M | 216.29M | 303.29M |
| Tax | 9.05M | 4.32M | 8.59M | 16.15M | 18.20M | 18.39M | 32.53M | 44.06M |
| Net profit | 54.38M | 35.17M | 47.91M | 93.10M | 140.21M | 136.31M | 183.76M | 259.22M |
| Basic EPS | 2 | 1 | 2 | 3 | 5 | 5 | 6 | 9 |
| Diluted EPS | 1.89 | 1.23 | 1.65 | 3.12 | 4.43 | 4.28 | 5.75 | 7.96 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 213.36M | 219.99M | 224.61M | 222.62M | 235.31M | 254.96M |
| Gross profit | 122.30M | 127.25M | 127.42M | 128.23M | 135.69M | 144.16M |
| Selling & admin expenses | 25.84M | 26.16M | 26.82M | 29.53M | 27.77M | 28.72M |
| Research & development | 33.23M | 35.45M | 36.74M | 37.97M | 37.08M | 39.26M |
| Operating profit | 63.23M | 65.64M | 63.86M | 60.73M | 70.84M | 76.19M |
| Pretax profit | 76.17M | 80.82M | 73.40M | 72.90M | 83.88M | 89.11M |
| Tax | 11.35M | 12.53M | 11.98M | 8.21M | 14.63M | 14.10M |
| Net profit | 64.82M | 68.29M | 61.42M | 64.69M | 69.26M | 75.01M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 2.03 | 2.14 | 1.90 | 1.94 | 2.04 | 2.20 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 281.58M | 302.93M | 558.70M | 566.52M | 612.95M | 710.22M | 901.95M | 1.41B |
| Cash & ST investments | 175.83M | 186.28M | 423.87M | 410.16M | 373.50M | 443.68M | 586.57M | 1.05B |
| Inventory | 41.79M | 48.36M | 61.73M | 78.67M | 116.60M | 138.20M | 156.60M | 183.67M |
| Total assets | 333.43M | 400.44M | 655.79M | 805.15M | 984.11M | 1.13B | 1.39B | 2.36B |
| Total current liabilities | 48.08M | 46.23M | 60.93M | 287.93M | 134.07M | 322.81M | 388.23M | 224.54M |
| Short-term debt | -- | 2.78M | 3.70M | 187.49M | 5.97M | 204.38M | 187.73M | 8.20M |
| Long-term debt | -- | -- | 178.81M | -- | 196.39M | -- | -- | 731.68M |
| Total liabilities | 52,690,000.00 | 85,904,000.00 | 284,248,000.00 | 331,400,000.00 | 397,142,000.00 | 383,055,000.00 | 462,627,000.00 | 1,042,298,000.00 |
| Total equity | 280.74M | 314.54M | 371.54M | 473.75M | 586.96M | 750.75M | 927.80M | 1.32B |
| Retained earnings | 158.54M | 193.71M | 241.62M | 334.72M | 478.07M | 614.38M | 798.15M | 1.06B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 875.74M | 901.36M | 1.45B | 1.41B | 1.49B | 1.45B |
| Cash & ST investments | 541.85M | 556.79M | 1.09B | 1.05B | 1.10B | 1.02B |
| Inventory | 174.83M | 182.02M | 183.10M | 183.67M | 178.85M | 185.27M |
| Total assets | 1.46B | 1.53B | 2.31B | 2.36B | 2.42B | 2.49B |
| Total current liabilities | 401.78M | 350.95M | 315.54M | 224.54M | 943.86M | 936.57M |
| Short-term debt | 188.07M | 156.94M | 98.12M | 8.20M | 742.14M | 743.66M |
| Long-term debt | -- | -- | 730.66M | 731.68M | -- | -- |
| Total liabilities | 481,662,000.00 | 437,216,000.00 | 1,136,749,000.00 | 1,042,298,000.00 | 1,028,105,000.00 | 1,024,160,000.00 |
| Total equity | 982.12M | 1.10B | 1.17B | 1.32B | 1.39B | 1.47B |
| Retained earnings | -- | 931.26M | -- | 1.06B | -- | -- |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 37.12M | 40.69M | 60.25M | 132.26M | 119.54M | 123.53M | 235.27M | 245.61M |
| Depreciation & amortization | 7.68M | 8.03M | 8.38M | 8.93M | 14.65M | 16.20M | 17.38M | 22.37M |
| Free cash flow | 33.45M | 19.42M | 53.81M | 127.45M | 98.23M | 106.34M | 218.05M | 217.92M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -4.80M | -7.16M | -12.55M | 0 | -21.42M | -112.00K | -30.00M | -35.00M |
| Ending cash balance | 22.88M | 31.75M | 232.30M | 126.70M | 111.72M | 107.57M | 157.78M | 214.78M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 68.55M | 45.66M | 71.28M | 60.13M | 40.08M | 40.92M |
| Depreciation & amortization | 4.90M | 5.47M | 5.68M | 6.31M | 5.81M | 5.99M |
| Free cash flow | 59.69M | 42.92M | 66.94M | 48.36M | 36.03M | 38.42M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -20.00M | 0 | 0 | -15.00M | 0 | 0 |
| Ending cash balance | 141.06M | 160.88M | 521.95M | 214.78M | 421.82M | 124.85M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 21.43 | 11.82 | 13.97 | 22.03 | 26.44 | 20.38 | 21.90 | 23.08 |
| ROA %i | 17.63 | 9.59 | 9.07 | 12.75 | 15.67 | 12.87 | 14.56 | 13.82 |
| ROIC %i | 20.42 | 9.39 | 9.68 | 14.81 | 17.75 | 12.86 | 14.30 | 13.42 |
| 5-year avg ROE %i | 14.87 | 14.49 | 15.22 | 18.48 | 19.14 | 18.93 | 20.94 | 22.76 |
| EBIT margin %i | 24.07 | 16.19 | 21.29 | 27.27 | 27.98 | 30.12 | 27.89 | 28.78 |
| FCF / sales %i | 12.91 | 8.86 | 19.97 | 30.63 | 17.21 | 20.53 | 32.43 | 24.75 |
| Current ratioi | 5.86 | 6.55 | 9.17 | 1.97 | 4.57 | 2.20 | 2.32 | 6.28 |
| Quick ratioi | 4.77 | 5.15 | 8.00 | 1.67 | 3.61 | 1.72 | 1.87 | 5.35 |
| Debt / assetsi | 0.00 | 8.32 | 32.70 | 27.44 | 25.00 | 21.53 | 16.98 | 33.85 |
| LT debt / equityi | -- | 9.71 | 56.71 | 7.06 | 40.90 | 5.30 | 5.21 | 60.00 |
| Interest coveragei | -- | -- | 66.09 | 26.83 | 124.56 | 121.48 | -- | -- |
| Revenue CAGR (3Y) %i | 19.14 | 11.12 | 6.66 | 18.33 | 36.40 | 24.34 | 17.35 | 15.55 |
| Net income CAGR (3Y) %i | 51.22 | 53.93 | 1.03 | 19.63 | 58.56 | 41.70 | 25.44 | 22.73 |
| FCF CAGR (3Y) %i | 16.02 | -- | -1.04 | 56.19 | 71.65 | 25.49 | 19.60 | 30.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 23.87 | 24.23 | 23.58 | 23.08 | 22.25 | 21.11 |
| ROA %i | 15.96 | 16.89 | 13.46 | 13.82 | 13.59 | 13.44 |
| ROIC %i | 15.67 | 16.20 | 12.80 | 13.42 | 13.20 | 13.07 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 28.71 | 28.94 | 29.11 | 28.78 | 28.93 | 28.97 |
| FCF / sales %i | 29.72 | 25.53 | 26.97 | 24.75 | 21.52 | 20.24 |
| Current ratioi | 2.18 | 2.57 | 4.58 | 6.28 | 1.58 | 1.55 |
| Quick ratioi | 1.66 | 1.98 | 3.91 | 5.35 | 1.35 | 1.31 |
| Debt / assetsi | 16.10 | 13.64 | 38.30 | 33.85 | 33.12 | 32.28 |
| LT debt / equityi | 4.85 | 4.77 | 67.10 | 60.00 | 4.18 | 4.08 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Products is the largest reported line at 79.02% of revenue, across 2 reported segments.
- The next-largest line, Services, is a distant second at 20.98% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Products79.02%
Services20.98%
Quote time 2026-10-08 06:32:02 · For reference only, not investment advice and not tailored to your situation.